The company took this step in response to an appeal made by the UN and WHO to drug makers to save some of their pandemic vaccines for poor nations. The offer was made during a meeting between the UN officials, vaccine makers and other health experts. In addition, Glaxo will reduce its pandemic vaccine prices for developing nations.
Glaxo has received orders from several countries to stockpile pandemic flu vaccine. But it will start making the vaccine as soon as it gets the vaccine’s key ingredient, a “seed stock” based on the virus.